Fabrinet Lags Peers as MSCI Exit Looms and Analysts Slash Targets

FN fell 16.9% over the past week, a steeper drop than the median 11.7% decline posted by its closest peer group, which included COHR down 20.1% and TTMI off 17.7%. The optical contract manufacturer now trades at $355.48, more than 40% below where the Street's consensus price target stood entering the week, a gap that reflects how quickly the narrative has shifted since August earnings.

Options positioning captures the change in tone precisely. Traders have rotated sharply away from put protection, with the put/call ratio dropping to 0.69, roughly 2.6 standard deviations below its 20-day average of 0.75. That is the most call-skewed reading of the past year, which might ordinarily suggest aggressive bullishness, but the context here matters: the stock has been grinding lower for a month, down 8.5%, so the skew more plausibly reflects expiring hedges and short-dated call writing than genuine bottom-fishing conviction. Short interest sits at 4.6% of the free float, broadly unremarkable, and the borrow market is loose, with availability near 9,070%, one of the most relaxed readings in months. Cost to borrow has fallen to 0.27%, a third-month decline. There is no meaningful squeeze pressure here, and nothing in the lending market that signals a short-side crowding problem.

The most consequential piece of data this week is mechanical rather than fundamental. ORTEX puts an 90% probability on Fabrinet being removed from the MSCI USA, MSCI World, MSCI Kokusai, and MSCI North America indices at the November 2026 Quarterly Review. The stock would need to close above $409.63, roughly 15% above current levels, to clear the index rule. At today's price of $355.48, the market cap of $13.0 billion falls well short of the $15.0 billion threshold. If removal is confirmed at the November 11 announcement, trackers would need to sell roughly $762 million worth of FN shares on the November 30 trade date, equivalent to 2.4 days of normal volume. At the same time, ORTEX forecasts an 89% chance of addition to the MSCI USA Small and MSCI World Small indices, with corresponding buying flows of $508 million and $254 million. The net picture is a shift in the investor base, from large-cap index weight to small-cap index weight, with announcement and trade dates that precede the November 2 earnings report by just over a week.

Analysts have been cutting targets into the weakness. Susquehanna lowered its target this week from $850 to $600, keeping a Positive rating. B. Riley cut from $598 to $431 with a Neutral stance last week. Both moves follow August post-earnings revisions from JPMorgan, Barclays and Needham, where targets were trimmed or held after Q4 results showed Datacom flat sequentially and NVIDIA-related revenue falling from nearly $200 million in the March quarter to roughly $125 million in the June quarter. The bull case leans on capacity expansion toward $9.8 billion by March 2027, DCI revenue running at a $1 billion annualised rate, and a return on invested capital near 40%. The bear case centres on four customers each exceeding 10% of FY26 revenue, Thai baht exposure, rising Thai tax rates, and limited 13-week order visibility against supplier lead times of roughly 30 weeks. The PE multiple has compressed to 16.9x on trailing earnings, down nearly 2.5 points over 30 days, with EV/EBITDA at 12.8x.

The institutional register adds a further dimension. T. Rowe Price added 385,000 shares in the quarter ended September, becoming a more prominent holder at 7.8% of shares. JPMorgan Asset Management added 362,000 shares over the same period. BlackRock and FMR both trimmed their disclosed stakes, with T. Rowe Price Associates' 13G/A filed in July showing its position fell from 11.3% to 5.4% at that date. No 13D activist is on the register. Insider activity since August has been dominated by tax-withholding transactions coded F, compensation mechanics rather than discretionary trades, alongside two open-market sales by the EVP of Sales and Marketing in early September totalling roughly $965,000.

The next scheduled earnings report on November 2 arrives after the November 11 MSCI announcement date but before the November 30 trade date, making the next three weeks unusually dense with potential catalysts. The price at which the index removal call flips, $409.63, is the number worth tracking between now and the rank date.